CRN

This paper considers systems in which two or more ligands bind independently to distinct sites in a common scaffold. Such systems arise in a range of applications, including immunotherapy and synthetic biology. We show that each stoichiometric compatibility class contains a unique steady state, and that this steady state is asymptotically stable. The main result gives a rigorous proof that the steady-state concentration of the fully bound complex, viewed as a function of the total scaffold concentration, has a unique maximum. This biphasic dose response behavior is a characteristic feature of scaffolding systems and, in the special case of two ligands, plays an important role in the design and analysis of bispecific antibody drugs.

This note considers a system in which three ligands can independently bind to a scaffold. Such systems arise in diverse applications, including immunotherapy and synthetic biology. It is shown that there are unique steady states in each conservation class, and these are asymptotically stable. The dependency of the steady-state amount of fully bound complex, as a function of total scaffold, is analyzed as well.

The goal of many single-cell studies on eukaryotic cells is to gain insight into the biochemical reactions that control cell fate and state. This paper introduces the concept of effective stoichiometric space (ESS) to guide the reconstruction of biochemical networks from multiplexed, fixed time-point, single-cell data. In contrast to methods based solely on statistical models of data, the ESS method leverages the power of the geometric theory of toric varieties to begin unraveling the structure of chemical reaction networks (CRN). This application of toric theory enables a data-driven mapping of covariance relationships in single cell measurements into stoichiometric information, one in which each cell subpopulation has its associated ESS interpreted in terms of CRN theory. In the development of ESS we reframe certain aspects of the theory of CRN to better match data analysis. As an application of our approach we process cytomery- and image-based single-cell datasets and identify differences in cells treated with kinase inhibitors. Our approach is directly applicable to data acquired using readily accessible experimental methods such as Fluorescence Activated Cell Sorting (FACS) and multiplex immunofluorescence.